Concepedia

Matthew A. Coelho

MA

11

Publications

1.9K

Citations

11

H-Index

2015

Active since

Affiliations

Wellcome Sanger Institute(Current)

AstraZeneca (United Kingdom)

European Bioinformatics Institute

University of Cambridge

Stanford University

Matthew A. Coelho is an author at Wellcome Sanger Institute specializing in genome editing, medicine, and gene editing.

ORCID

Top concepts

Publications per year

2015–2024

11

Publications

11

Oncogenic RAS Signaling Promotes Tumor Immunoresistance by Stabilizing PD-L1 mRNA

Matthew A. Coelho, Sophie de Carné Trécesson, Sareena Rana et al. · Immunity · 2017 · 644 citations · Full text

High-content CRISPR screening

Christoph Bock, Paul Datlinger, Florence M. Chardon et al. · Nature Reviews Methods Primers · 2022 · 541 citations

, , +5

High-content CRISPR screening

Christoph Bock, Paul Datlinger, Florence M. Chardon et al. · Nature Reviews Methods Primers · 2022 · 244 citations · Full text

, , +5

BE-FLARE: a fluorescent reporter of base editing activity reveals editing characteristics of APOBEC3A and APOBEC3B

Matthew A. Coelho, Songyuan Li, Luna Simona Pane et al. · BMC Biology · 2018 · 95 citations · Full text

Base editing screens map mutations affecting interferon-γ signaling in cancer

Matthew A. Coelho, Sarah Cooper, Magdalena E Strauß et al. · Cancer Cell · 2023 · 83 citations · Full text

Rows per page

1–5 of 11